In the BioHarmony Drug Report Database

"Preview" Icon

Oteracil

Teysuno (oteracil) is a small molecule pharmaceutical. Oteracil was first approved as Teysuno on 2011-03-14. It has been approved in Europe to treat stomach neoplasms.

 

Trade Name

 

Teysuno
 

Common Name

 

oteracil
 

ChEMBL ID

 

CHEMBL181932
 

Indication

 

stomach neoplasms
 

Drug Class

 

Uracil type antineoplastics

Image (chem structure or protein)

Oteracil structure rendering